372: Biotech Billionaire Anne Wojcicki, Cofou...

Up next

690: (Solo) The Truth About Selling Your Business (From Someone Who Said No)

At some point, if you are building a DTC brand and getting traction, someone is going to reach out. An aggregator, a private equity firm, a bigger competitor. And most founders have no idea what to do when that happens because nobody ever walks you through it. Here is the thing: ... Show more

. 11min 44sec

689: I Sold ONE Product in ONE Color - Then Exited for Half a Billion

Rob Ward exited Quad Lock last year for half a billion dollars. He never took a cent of outside investment to build it, was profitable every single month from day one, and ran the business with a skeleton team for years while competitors burned cash chasing scale. His first produ ... Show more

. 54min 13sec

Recommended Episodes

20VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

Anne Wojcicki is the Founder & CEO @ 23andme, offering DNA testing with the most comprehensive ancestry breakdown, personalized health insights, and more. To date, A ...

. 41min 13sec

23andMe's Fatal Flaw | Great Expectorations | 1

Business Wars

When Silicon Valley power-player Anne Wojcicki sees gold in genetics, she forms 23andMe. She wants to bring genetic testing to the masses. But behind the hype and celebrity endorsements, can she build a company that’s selling more than just an expensive novelty product? Be the fi ... Show more

. 36min 42sec

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

HBR IdeaCast

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and ... Show more

. 23min 55sec

23andMe's Fatal Flaw | Guess Who’s Back | 3

Business Wars

Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show more

. 37min 55sec